{
"info": {
"nct_id": "NCT01693276",
"official_title": "Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer",
"inclusion_criteria": "* Histologically or cytologically proven carcinoma of the pancreas that is locally advanced\n* ECOG performance status 0- 2\n* Adequate labs\n* No prior abdominal radiation therapy\n* No other concurrent clinically evident malignancy, except inactive nonmelanoma skin cancer, inactive cervical cancer, or other cancer for which the patient has been disease-free for 5 years\n* All disease must be encompassed within a radiotherapy portal\n* Not pregnant or nursing\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Patient has metastatic disease on radiological staging\n* systemic therapy.\n* Patient has known active infection with HIV, hepatitis C or hepatitis B\n* Patient has serious medical risk factors involving any of the major organ systems such that the Investigator considers it unsafe for the patient to receive an experimental research drug.\n* Patient is deemed to be have obvious resectable disease at presentation\n* Received any investigational agent within a month prior to enrollment.\n* Neuroendocrine tumors of the pancreas",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Histologically or cytologically proven carcinoma of the pancreas that is locally advanced",
"criterions": [
{
"exact_snippets": "Histologically or cytologically proven carcinoma of the pancreas",
"criterion": "carcinoma of the pancreas",
"requirements": [
{
"requirement_type": "confirmation method",
"expected_value": [
"histologically",
"cytologically"
]
}
]
},
{
"exact_snippets": "locally advanced",
"criterion": "carcinoma of the pancreas",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "locally advanced"
}
]
}
]
},
{
"line": "* ECOG performance status 0- 2",
"criterions": [
{
"exact_snippets": "ECOG performance status 0- 2",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* Adequate labs",
"criterions": [
{
"exact_snippets": "Adequate labs",
"criterion": "laboratory results",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
}
]
},
{
"line": "* No prior abdominal radiation therapy",
"criterions": [
{
"exact_snippets": "No prior abdominal radiation therapy",
"criterion": "abdominal radiation therapy",
"requirements": [
{
"requirement_type": "prior treatment",
"expected_value": false
}
]
}
]
},
{
"line": "* No other concurrent clinically evident malignancy, except inactive nonmelanoma skin cancer, inactive cervical cancer, or other cancer for which the patient has been disease-free for 5 years",
"criterions": [
{
"exact_snippets": "No other concurrent clinically evident malignancy",
"criterion": "concurrent clinically evident malignancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "except inactive nonmelanoma skin cancer",
"criterion": "inactive nonmelanoma skin cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "except ... inactive cervical cancer",
"criterion": "inactive cervical cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "except ... other cancer for which the patient has been disease-free for 5 years",
"criterion": "other cancer",
"requirements": [
{
"requirement_type": "disease-free duration",
"expected_value": {
"operator": ">=",
"value": 5,
"unit": "years"
}
}
]
}
]
},
{
"line": "* All disease must be encompassed within a radiotherapy portal",
"criterions": [
{
"exact_snippets": "All disease must be encompassed within a radiotherapy portal",
"criterion": "disease location",
"requirements": [
{
"requirement_type": "location",
"expected_value": "within a radiotherapy portal"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Patient has metastatic disease on radiological staging",
"criterions": [
{
"exact_snippets": "metastatic disease",
"criterion": "metastatic disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "radiological staging",
"criterion": "radiological staging",
"requirements": [
{
"requirement_type": "method",
"expected_value": "radiological"
}
]
}
]
},
{
"line": "* systemic therapy.",
"criterions": [
{
"exact_snippets": "systemic therapy",
"criterion": "systemic therapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patient has known active infection with HIV, hepatitis C or hepatitis B",
"criterions": [
{
"exact_snippets": "known active infection with HIV",
"criterion": "HIV infection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "known active infection with ... hepatitis C",
"criterion": "hepatitis C infection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "known active infection with ... hepatitis B",
"criterion": "hepatitis B infection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patient has serious medical risk factors involving any of the major organ systems such that the Investigator considers it unsafe for the patient to receive an experimental research drug.",
"criterions": [
{
"exact_snippets": "serious medical risk factors involving any of the major organ systems",
"criterion": "medical risk factors",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "serious"
},
{
"requirement_type": "involvement",
"expected_value": "major organ systems"
}
]
},
{
"exact_snippets": "Investigator considers it unsafe for the patient to receive an experimental research drug",
"criterion": "safety for receiving experimental research drug",
"requirements": [
{
"requirement_type": "assessment",
"expected_value": "unsafe"
}
]
}
]
},
{
"line": "* Patient is deemed to be have obvious resectable disease at presentation",
"criterions": [
{
"exact_snippets": "obvious resectable disease",
"criterion": "disease resectability",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Received any investigational agent within a month prior to enrollment.",
"criterions": [
{
"exact_snippets": "Received any investigational agent within a month prior to enrollment.",
"criterion": "investigational agent",
"requirements": [
{
"requirement_type": "time since last administration",
"expected_value": {
"operator": "<=",
"value": 1,
"unit": "month"
}
}
]
}
]
},
{
"line": "* Neuroendocrine tumors of the pancreas",
"criterions": [
{
"exact_snippets": "Neuroendocrine tumors of the pancreas",
"criterion": "neuroendocrine tumors",
"requirements": [
{
"requirement_type": "location",
"expected_value": "pancreas"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"line": "* Not pregnant or nursing",
"criterions": [
{
"exact_snippets": "Not pregnant",
"criterion": "pregnancy status",
"requirements": [
{
"requirement_type": "status",
"expected_value": false
}
]
},
{
"exact_snippets": "not ... nursing",
"criterion": "nursing status",
"requirements": [
{
"requirement_type": "status",
"expected_value": false
}
]
}
]
}
],
"failed_exclusion": [],
"failed_miscellaneous": []
}